Matches in Nanopublications for { ?s ?p "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP517563.RAZl_74LwNVMlrfQ4FKId2zoY_vtSZ-H-9cPMOx1qMcgQ130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517563.RAZl_74LwNVMlrfQ4FKId2zoY_vtSZ-H-9cPMOx1qMcgQ130_provenance.
- NP517580.RAWhuQPzg-TduNzaolI3EDxCX2fLSNRWCbLPQzrEzUPBE130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517580.RAWhuQPzg-TduNzaolI3EDxCX2fLSNRWCbLPQzrEzUPBE130_provenance.
- assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095410.RAmU5okzrYro8dFnTTNEYzn55jBtdtvg5Kg5u1mMq3zyc130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095410.RAmU5okzrYro8dFnTTNEYzn55jBtdtvg5Kg5u1mMq3zyc130_provenance.
- NP1095413.RAlxozjES3RfxbBw-NTncRXZ-zjAOwutfCE3CNE5lpfUI130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095413.RAlxozjES3RfxbBw-NTncRXZ-zjAOwutfCE3CNE5lpfUI130_provenance.
- NP517546.RA-cAx31pjZH3EOlZghZS_3u71Mjx6gQgFLJ2GbVs3zZY130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517546.RA-cAx31pjZH3EOlZghZS_3u71Mjx6gQgFLJ2GbVs3zZY130_provenance.